Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
LB Pharmaceuticals Inc (NASDAQ: LBRX)
LBRX Stock Predictions and Ratings
WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
44.20%
LBRX Stock Analysis
LBRX
PE Ratio:
LBRX
PEG Ratio:
Not Available
LBRX
Forward EPS Growth (12 month):
0.00%
LBRX
PS Ratio:
LBRX
PSG Ratio:
Not Available
LBRX
Forward Revenue Growth (12 month):
0.00%
LBRX Articles
No data was found